Clinical Trial Update: Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for borderline resectable pancreatic cancer focusing on neoadjuvant chemoradiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN